Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 17 studies | 38% ± 21% | |
epithelial cell | 5 studies | 31% ± 8% | |
deuterosomal cell | 3 studies | 23% ± 4% | |
abnormal cell | 3 studies | 20% ± 3% | |
glutamatergic neuron | 3 studies | 29% ± 6% | |
dendritic cell | 3 studies | 23% ± 5% | |
basal cell | 3 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 1920.60 | 258 / 258 | 100% | 71.69 | 230 / 230 |
esophagus | 100% | 2404.94 | 1445 / 1445 | 100% | 75.90 | 183 / 183 |
liver | 100% | 1463.50 | 226 / 226 | 100% | 57.64 | 406 / 406 |
ovary | 100% | 2314.23 | 180 / 180 | 100% | 92.22 | 430 / 430 |
thymus | 100% | 2143.22 | 653 / 653 | 100% | 72.89 | 605 / 605 |
uterus | 100% | 2620.75 | 170 / 170 | 100% | 108.61 | 459 / 459 |
brain | 100% | 4186.69 | 2640 / 2642 | 100% | 90.76 | 705 / 705 |
intestine | 100% | 2223.16 | 966 / 966 | 99% | 105.65 | 524 / 527 |
stomach | 100% | 1640.67 | 359 / 359 | 99% | 94.60 | 284 / 286 |
prostate | 100% | 2235.44 | 245 / 245 | 99% | 72.79 | 498 / 502 |
skin | 100% | 2361.43 | 1808 / 1809 | 99% | 92.61 | 468 / 472 |
kidney | 100% | 2283.91 | 89 / 89 | 99% | 58.03 | 891 / 901 |
bladder | 100% | 2338.29 | 21 / 21 | 98% | 104.12 | 496 / 504 |
breast | 100% | 1861.32 | 459 / 459 | 98% | 67.44 | 1097 / 1118 |
lung | 99% | 1760.26 | 574 / 578 | 98% | 70.23 | 1131 / 1155 |
pancreas | 100% | 1092.61 | 327 / 328 | 97% | 70.38 | 173 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 99.05 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 115.41 | 29 / 29 |
spleen | 100% | 1469.96 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 93.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 91.64 | 1 / 1 |
adipose | 100% | 1589.34 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1717.64 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1797.14 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1947.24 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 72% | 810.33 | 670 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0006457 | Biological process | protein folding |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0005615 | Cellular component | extracellular space |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0004857 | Molecular function | enzyme inhibitor activity |
GO_0140313 | Molecular function | molecular sequestering activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
GO_0000774 | Molecular function | adenyl-nucleotide exchange factor activity |
Gene name | HSPBP1 |
Protein name | HSPA (Hsp70) binding protein 1 Hsp70-binding protein 1 (HspBP1) (Heat shock protein-binding protein 1) (Hsp70-binding protein 2) (HspBP2) (Hsp70-interacting protein 1) (Hsp70-interacting protein 2) |
Synonyms | HSPBP PP1845 |
Description | FUNCTION: Inhibits HSPA1A chaperone activity by changing the conformation of the ATP-binding domain of HSPA1A and interfering with ATP binding. Interferes with ubiquitination mediated by STUB1 and inhibits chaperone-assisted degradation of immature CFTR. . |
Accessions | ENST00000433386.7 [Q9NZL4-1] ENST00000593263.5 K7EMM7 ENST00000587959.1 K7EQQ0 ENST00000587551.1 ENST00000255631.9 [Q9NZL4-1] ENST00000587922.5 [Q9NZL4-1] K7EN20 ENST00000588971.1 K7EKM6 ENST00000585698.1 K7EL16 K7ERT9 ENST00000585927.1 Q9NZL4 |